EATG » Cure

Cure

European Cure Review concentrates on HIV therapeutic vaccines

A cure for HIV would almost inevitably have to involve a vaccine to improve the body’s natural ability to control HIV, a seminar on European HIV cure research heard recently.…

Understanding the Berlin patient’s unexpected cure of HIV

New tool developed to study stem cell transplants as a potential way to treat HIV A decade ago, the medical world was shocked when a patient in Berlin, Germany, had…

HIV remission: the quest to turn lessons from exceptional cases into solutions

The case of an HIV-infected child in South Africa who has been in remission for nearly nine years without taking any antiretroviral drugs has provided further proof that HIV remission…

ABX464 reduces HIV reservoir but doesn’t delay viral rebound

ABX464, a new drug that stimulates the clearance of HIV from infected cells, reduces the reservoir of HIV DNA in the body but does not delay the rebound in viral…

New research opens the door to ‘functional cure’ for HIV

JUPITER, FL – October 17, 2017 – In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps…

October 2017 issue of Journal of Virus Eradication now online

Researchers create molecule that could ‘kick and kill’ HIV

In lab animals, a particle developed by UCLA, Stanford, NIH scientists awakens dormant virus cells and then knocks them out Current anti-AIDS drugs are highly effective at making HIV undetectable…

Study quantifies scope of HIV ‘reservoir’ in infected people and points to potential curative strategies

MINNEAPOLIS, October 3, 2017 – A new study in the journal Nature Medicine suggests current antiretroviral therapies for the treatment of HIV infection are not making it into the tissues…

ABIVAX’s ABX464 reduces HIV reservoir in blood in second Phase 2a clinical trial

ABX464 first ever drug candidate to show statistically significant (p<0.01) reduction in HIV viral reservoir PARIS, Sept. 28, 2017 7:30 a.m. CEST – ABIVAX (Euronext Paris: FR0012333284 – ABVX), an innovative…

The Campbell Foundation awards grant to develop gene editing tool to destroy latent HIV cells in lymph nodes

Sept. 26, 2017 – FORT LAUDERDALE, FL –  The Campbell Foundation, a nonprofit organization dedicated to funding HIV/AIDS research, has awarded an $80,000 grant to Kristine Yoder, PhD, to develop…

1 2 3 12